Annual influenza vaccination: immune response in patients over 10 years

P A Gross1, C R Denning, P F Gaerlan

  • 1Department of Internal Medicine, Hackensack University Medical Center, NJ, USA.

Vaccine
|September 1, 1996
PubMed

Insights

Annual influenza immunization in cystic fibrosis (CF) patients consistently generates protective antibody levels. This 10-year study found no significant change in antibody titers or Shwachman scores, indicating sustained vaccine effectiveness.

Area of Science:

  • Immunology
  • Pediatrics
  • Pulmonology

Background:

  • Cystic Fibrosis (CF) patients face increased risk from influenza.
  • Annual influenza vaccination is recommended for individuals with CF.
  • The long-term impact of repeated influenza immunization on antibody response in CF patients is not well-defined.

Purpose of the Study:

  • To evaluate the effect of repeated annual influenza immunization on serum antibody levels in children and young adults with CF.
  • To assess the durability of the immune response to influenza vaccination over a 10-year period in this population.

Main Methods:

  • A 10-year observational cohort study was conducted.
  • Thirty-eight children and young adults with CF were included.
  • Serum hemagglutination inhibition (HI) antibody titers were measured annually pre- and post-vaccination.

Main Results:

  • No significant upward or downward trend in geometric mean serum HI antibody titers was observed over 10 years.
  • The majority of participants achieved presumably protective antibody titers (≥1:40) annually for all tested influenza strains (A/H3N2, A/H1N1, B).
  • Mean Shwachman scores remained stable, with no significant difference between the initial and final scores (77 vs. 76).

Conclusions:

  • Repeated annual influenza vaccination effectively induces protective serum antibody levels in most children and young adults with CF.
  • The study suggests sustained immunogenicity and clinical stability associated with annual influenza immunization in this cohort over a decade.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Active versus Passive Immunity01:31

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...